Multiple Myeloma

Showing NaN - NaN of 99

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Myeloma Trial in France, United States (M3258, Dexamethasone)

Terminated
  • Multiple Myeloma
  • Denver, Colorado
  • +6 more
May 10, 2021

Multiple Myeloma Trial in United States (bb21217)

Active, not recruiting
  • Multiple Myeloma
  • bb21217
  • San Francisco, California
  • +10 more
Mar 17, 2021

Multiple Myeloma Trial in Worldwide (LBH589)

Completed
  • Multiple Myeloma
  • Miami Shores, Florida
  • +15 more
Dec 16, 2020

Multiple Myeloma Trial in United States (bb2121)

Active, not recruiting
  • Multiple Myeloma
  • bb2121
  • Stanford, California
  • +8 more
Dec 2, 2020

Multiple Myeloma Trial in United States (Carfilzomib, Lenalidomide, Dexamethasone)

Completed
  • Multiple Myeloma
  • Bakersfield, California
  • +58 more
Oct 15, 2020

Multiple Myeloma Trial in United States (rhIL-2, PNK-007)

Completed
  • Multiple Myeloma
  • Minneapolis, Minnesota
  • +6 more
Jul 20, 2020

Multiple Myeloma Trial in United States (Lenalidomide)

Completed
  • Multiple Myeloma
  • Tucson, Arizona
  • +41 more
Apr 27, 2020

Multiple Myeloma Trial in United States (Pomalidomide, Bortezomib, Dexamethasone)

Completed
  • Multiple Myeloma
  • Atlanta, Georgia
  • +5 more
Apr 3, 2020

Multiple Myeloma Trial in United States (PCI-32765, Dexamethasone)

Completed
  • Multiple Myeloma
  • La Jolla, California
  • +10 more
Mar 2, 2020

Longterm Follow-up of Subjects Treated With bb2121

Completed
  • Multiple Myeloma
  • Safety and efficacy assessments
  • Palo Alto, California
  • +8 more
Jan 20, 2020

Multiple Myeloma Trial in Canada, United States (Pomalidomide)

Approved for marketing
  • Multiple Myeloma
  • Duarte, California
  • +41 more
Nov 7, 2019

Multiple Myeloma Trial in United States (SGN-CD352A)

Terminated
  • Multiple Myeloma
  • Scottsdale, Arizona
  • +10 more
Aug 8, 2019

Multiple Myeloma Trial in United States (BT062 , intravenous administration)

Completed
  • Multiple Myeloma
  • BT062 , intravenous administration
  • Duarte, California
  • +9 more
Jul 22, 2019

Multiple Myeloma Trial in Worldwide (Carfilzomib, Bortezomib, Dexamethasone)

Completed
  • Multiple Myeloma
  • Burbank, California
  • +240 more
Apr 1, 2019

Multiple Myeloma Trial in United States (Ixazomib, Lenalidomide, Dexamethasone)

Completed
  • Multiple Myeloma
  • Berkeley, California
  • +19 more
Mar 20, 2019

MMRF Molecular Profiling Protocol

Recruiting
  • Multiple Myeloma
  • Plasma Malignancy
  • genetic sequencing
  • Scottsdale, Arizona
  • +19 more
Mar 15, 2019

Multiple Myeloma Trial in Worldwide (Daratumumab)

Approved for marketing
  • Multiple Myeloma
  • Phoenix, Arizona
  • +78 more
Jan 11, 2019

Multiple Myeloma Trial in Worldwide (DARATUMUMAB, DURVALUMAB)

Completed
  • Multiple Myeloma
  • Duarte, California
  • +24 more
Sep 18, 2018

Multiple Myeloma to Personal Assessment of Genetic Profile

Active, not recruiting
  • Multiple Myeloma
    • Scottsdale, Arizona
    • +72 more
    Aug 14, 2018

    Non-Hodgkin's Lymphoma (NHL), Multiple Myeloma, Waldenstrom's Macroglobulinemia (WM) Trial in United States (CB-839, CB-839 and

    Completed
    • Non-Hodgkin's Lymphoma (NHL)
    • +4 more
    • Scottsdale, Arizona
    • +6 more
    Jul 16, 2018

    Multiple Myeloma, Solid Tumors Trial in Canada, United States (Carfilzomib)

    Completed
    • Multiple Myeloma
    • Solid Tumors
    • Scottsdale, Arizona
    • +22 more
    Apr 9, 2018

    Multiple Myeloma Trial in West Hollywood, Hackensack (Carfilzomib and Dexamethasone)

    Unknown status
    • Multiple Myeloma
    • Carfilzomib and Dexamethasone
    • West Hollywood, California
    • +1 more
    Mar 1, 2018

    Leukemia, Acute Leukemia, Acute Lymphocytic Leukemia Trial in Hackensack, New York, Chapel Hill (Writing A (Experimental

    Completed
    • Leukemia
    • +5 more
    • Writing A (Experimental informative writing)
    • +3 more
    • Hackensack, New Jersey
    • +2 more
    Nov 14, 2017